Development of Gastroretentive Floating Combination Tablets Containing Amoxicillin Trihydrate 500 mg and Levofloxacin 125 mg for Eradicating Resistant <i>Helicobacter pylori</i>

<b>Background/Objectives:</b> The aim of this work was to prepare and characterize gastroretentive floating combination tablets (GRCTs) containing 500 mg of amoxicillin trihydrate (AMX) and 125 mg of levofloxacin (LVX) that provide sustained drug release and stability at gastric pH levels for the er...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Da Hun Kim, Sa-Won Lee, Jun Hak Lee, Jin Woo Park, Sung Mo Park, Han-Joo Maeng, Tae-Sung Koo, Kwan Hyung Cho
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-09-01
Colecção:	Pharmaceutics
Assuntos:	gastroretentive floating combination tablets sustained release amoxicillin levofloxacin <i>Helicobacter pylori</i> effervescent tablets
Acesso em linha:	https://www.mdpi.com/1999-4923/16/10/1242
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!